Aligos Therapeutics Stock Forum

$Aligos Therapeutics(ALGS.US)$
Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.
Aligos Therapeutics (Nasdaq: ALGS) has announced a clinical trial collaboration with Xiamen Amoytop Biotech to evaluate the combination of ALG-000184 and PEGBING® (Mipeginterferon alfa-2b) in chronic hepatitis B (CHB) patients in China. Amoytop will sponsor a Phase 1b exploratory study to assess the efficacy and safety of this combination.
ALG-000184 is a potent oral cap...

$Aligos Therapeutics(ALGS.US)$
NEWS
Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH
Aligos Therapeutics (Nasdaq: ALGS) has completed enrollment for its Phase 2a HERALD study of ALG-055009, targeting metabolic dysfunction-associated steatohepatitis (MASH). The study enrolled around 100 subjects with liver fibrosis. Topline safety and efficacy data are expected in early Q4 2024.
Dr. Rohit Loomba, a renowned expert in gast...

$Aligos Therapeutics(ALGS.US)$ Aligos Therapeutics Presents Positive Clinical Data at Escmid 2024 From the Alg-097558 Phase 1 Study

$Aligos Therapeutics(ALGS.US)$
NEWS
Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study
The data shows that the pan-coronavirus protease inhibitor ALG-097558 was well tolerated and does not require ritonavir boosting.
The PK profile supports twice daily ritonavir-free dosing without a food effect.
Aligos has developed a robust clinical pipeline of three potentially best-in-class drug candidates.
The presentation highlights the best-in-class potent...

$Aligos Therapeutics(ALGS.US)$ Mirum’s LIVMARLI receives positive reimbursement recommendation by Canada’s CADTH

$Aligos Therapeutics(ALGS.US)$ Found this

$Aligos Therapeutics(ALGS.US)$ Ah! Phase one results coming here directly! Still if playing secure profits when presented

$Aligos Therapeutics(ALGS.US)$ watching but may be a P&D!